Xenetic Biosciences Inc (XBIO)

Xenetic Biosciences Inc (XBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $5.2M; returns 1 day -10.9%, 1 week -13.6%, 1 year -55.4%.

Xenetic Biosciences Inc. (XBIO) is a biopharmaceutical company focused on advancing innovative immuno-oncology technologies for treating difficult cancers. Their primary focus is on their DNase I Oncology Platform, designed to improve outcomes of existing cancer treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs).

Groups XBIO belongs to

• Biotechnology
• Oncology
• Immunotherapy
• Healthcare
• Biopharmaceutical
• Cancer Therapeutics
• Royalty Streams
• Clinical Stage Biotech
• Pancreatic Cancer

XBIO financial model: income statement, cash flow and balance sheet